Financier Jonathan Thomas selected to lead California stem cell agency
A financier has been selected to head California’s public stem cell research agency. A financier has been selected to head California’s
public stem cell
research agency. The board of the California Institute for Regenerative
Medicine selected its next chairman, Jonathan Thomas, by a vote of 14 to 11.
Thomas, an investment banker, will succeed longtime chairman Robert Klein.
Klein’s reign as chairman has been rife with controversy due to his hands-on
approach at the agency, which led to high turnover among the agency’s chief
executives. Klein had planned to resign late last year, but agreed to stay on
for another six months when his candidate withdrew from the pool amid
accusations of backroom deals. Thomas narrowly won the majority of the board’s
votes. ~ San Francisco
Examiner, Jun 23
Financier Jonathan Thomas selected to lead California stem cell agency
Jared Yee
stem cell research
stem cells
US
- Prescribe morning-after pills to young teenagers, say US pediatric group - November 30, 2012
- Bahrain sentences protest docs to prison - November 28, 2012
- Terry Pratchett assisted suicide documentary wins International Emmy - November 27, 2012
More Stories
Mortality rates for American kids are rising for the first time in 50 years
US President Joe Biden is so concerned about the future of American children that he inserted a mandate for affordable...
Will Pope Francis be composted?
Will Pope Francis be composted instead of buried in St Peter’s Basilica in Rome with his predecessors? It’s unlikely. But...
The virtues and the vices of the outrageous
A Norwegian bioethicist, Anna Smajdor, recently set out a case for “Whole Body Gestational Donation” – using the wombs of...
More than 200 people have been treated with experimental CRISPR therapies
Scientists believe that CRISPR gene editing technologies will transform medicine. But how many people have been treated so far? According...
Asia-Pacific IVF market could reach US$46 billion by 2031
According to a market survey by Allied Market Research, IVF is booming in the Asia-Pacific region. The market size was...
Third global summit on human genome editing: Moving on after the He experiment
The much anticipated Third International Summit on Human Genome Editing was held in London earlier this month to explore the...